GlassScriptPhysician profile
Thomas Huddleston
NPI 1184694424
$838.11
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $234 · 2021: $315.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $212.17 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $179.50 | 2019-2021 | |
| Smith+Nephew, INC. | $164.02 | 2019-2021 | |
| Depuy Synthes Sales INC. | $35.74 | 2019 | |
| Integra Lifesciences Corporation | $31.64 | 2019 | |
| Heron Therapeutics, INC. | $31.05 | 2021 | |
| Acell, INC. | $25.09 | 2020 | |
| Daiichi Sankyo INC. | $21.20 | 2021 | |
| Radius Health, INC. | $17.64 | 2021 | |
| Innovation Technologies INC | $17.55 | 2020 | |
| Ethicon US, LLC | $15.89 | 2019 | |
| Tactile Systems Technology INC | $12.85 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.64 | 2019 | |
| Convatec INC. | $12.57 | 2021 | |
| Endo Pharmaceuticals INC. | $12.44 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12.41 | 2021 | |
| Zyla Life Sciences, INC. | $11.97 | 2019 | |
| Orthofix Medical, INC. | $11.74 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Huddleston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.